The National Institutes of Health (NIH) is inviting small businesses to submit proposals for the development of innovative devices, diagnostic technologies, or digital health tools aimed at the treatment, detection, and diagnosis of pediatric and rare cancers. The solicitation encourages "out of the box" ideas that demonstrate proof of concept for transformative technologies, emphasizing that projects should not merely optimize existing solutions but rather introduce novel approaches that could significantly enhance cancer care. This initiative is part of the SBIR Phase I program, with applications due by October 17, 2025, and aims to support high-risk, high-reward projects that may lead to groundbreaking advancements in cancer management. Interested parties can find more details and submit proposals through the official NIH SBIR website.